Rokavec M - Search Results

1

The transient and constitutive inflammatory signaling in tumorigenesis.

Rokavec M, Luo JL. Rokavec M, et al. Cell Cycle. 2012 Jul 15;11(14):2587-8. doi: 10.4161/cc.21139. Epub 2012 Jul 15. Cell Cycle. 2012. PMID: 22751429 Free PMC article.

Comment on: Rokavec M, et al. Mol Cell 2012; 45:777-89....

2

CCL17 Promotes Colitis-Associated Tumorigenesis Dependent on the Microbiota.

Metzger R, Winter L, Bouznad N, Garzetti D, von Armansperg B, Rokavec M, Lutz K, Schäfer Y, Krebs S, Winheim E, Friedrich V, Matzek D, Öllinger R, Rad R, Stecher B, Hermeking H, Brocker T, Krug AB. Metzger R, et al. Among authors: rokavec m. J Immunol. 2022 Dec 1;209(11):2227-2238. doi: 10.4049/jimmunol.2100867. J Immunol. 2022. PMID: 36426975

3

Nidogen-1/NID1 Function and Regulation during Progression and Metastasis of Colorectal Cancer.

Rokavec M, Jaeckel S, Hermeking H. Rokavec M, et al. Cancers (Basel). 2023 Nov 7;15(22):5316. doi: 10.3390/cancers15225316. Cancers (Basel). 2023. PMID: 38001576 Free PMC article.

4

Meta-analysis of miR-34 target mRNAs using an integrative online application.

Rokavec M, Huang Z, Hermeking H. Rokavec M, et al. Comput Struct Biotechnol J. 2022 Dec 6;21:267-274. doi: 10.1016/j.csbj.2022.12.003. eCollection 2023. Comput Struct Biotechnol J. 2022. PMID: 36582442 Free PMC article.

5

Curcumin activates a ROS/KEAP1/NRF2/miR-34a/b/c cascade to suppress colorectal cancer metastasis.

Liu C, Rokavec M, Huang Z, Hermeking H. Liu C, et al. Among authors: rokavec m. Cell Death Differ. 2023 Jul;30(7):1771-1785. doi: 10.1038/s41418-023-01178-1. Epub 2023 May 20. Cell Death Differ. 2023. PMID: 37210578 Free PMC article.

6

IL6-mediated suppression of miR-200c directs constitutive activation of inflammatory signaling circuit driving transformation and tumorigenesis.

Rokavec M, Wu W, Luo JL. Rokavec M, et al. Mol Cell. 2012 Mar 30;45(6):777-89. doi: 10.1016/j.molcel.2012.01.015. Epub 2012 Feb 23. Mol Cell. 2012. PMID: 22364742 Free PMC article.

7

Cytokines-activated nuclear IKKα-FAT10 pathway induces breast cancer tamoxifen-resistance.

Chen X, Wu W, Jeong JH, Rokavec M, Wei R, Feng S, Schroth W, Brauch H, Zhong S, Luo JL. Chen X, et al. Among authors: rokavec m. Sci China Life Sci. 2024 Apr 1. doi: 10.1007/s11427-023-2460-0. Online ahead of print. Sci China Life Sci. 2024. PMID: 38565741

8

The p53/miR-34 axis in development and disease.

Rokavec M, Li H, Jiang L, Hermeking H. Rokavec M, et al. J Mol Cell Biol. 2014 Jun;6(3):214-30. doi: 10.1093/jmcb/mju003. Epub 2014 May 9. J Mol Cell Biol. 2014. PMID: 24815299 Review.

9

Characterization of a p53/miR-34a/CSF1R/STAT3 Feedback Loop in Colorectal Cancer.

Shi X, Kaller M, Rokavec M, Kirchner T, Horst D, Hermeking H. Shi X, et al. Among authors: rokavec m. Cell Mol Gastroenterol Hepatol. 2020;10(2):391-418. doi: 10.1016/j.jcmgh.2020.04.002. Epub 2020 Apr 15. Cell Mol Gastroenterol Hepatol. 2020. PMID: 32304779 Free PMC article.

10

Soluble IL6R represents a miR-34a target: potential implications for the recently identified IL-6R/STAT3/miR-34a feed-back loop.

Li H, Rokavec M, Hermeking H. Li H, et al. Among authors: rokavec m. Oncotarget. 2015 Jun 10;6(16):14026-32. doi: 10.18632/oncotarget.4334. Oncotarget. 2015. PMID: 26091352 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page